One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study.

Maria Sole ChimentiGiulia Lavinia FontiPaola ConigliaroFlavia SunziniRossana ScrivoLuca NavariniPaola TriggianeseGiusy PelusoPalma ScolieriRosalba CaccavaleAndrea Picchianti DiamantiErica De MartinoSimonetta SalemiDomenico BirraAlessio AltobelliMarino ParoliVincenzo BruzzeseBruno LaganàElisa GremeseFabrizio ContiAntonella AfeltraRoberto Perricone

Published in: Expert opinion on biological therapy (2020)

Secukinumab is effective and safe in patients with AS and PsA in a real-life setting.

Keyphrases

ankylosing spondylitis
prostate cancer
rheumatoid arthritis
disease activity
randomized controlled trial
systematic review
radical prostatectomy
systemic lupus erythematosus